[HTML][HTML] Cardiometabolic effects of psychotropic medications

O Abosi, S Lopes, S Schmitz… - … molecular biology and …, 2018 - degruyter.com
Background Many psychiatric disorders including schizophrenia, bipolar disorder and major
depression convey an excess burden of cardiovascular morbidity and mortality. The …

Risks and benefits of medications for panic disorder: a comparison of SSRIs and benzodiazepines

LA Quagliato, RC Freire, AE Nardi - Expert opinion on drug safety, 2018 - Taylor & Francis
Introduction: Panic disorder (PD) is a prevalent and disabling anxiety disorder that can be
treated effectively. Selective serotonin reuptake inhibitors (SSRIs) and benzodiazepines are …

Effects of sodium benzoate, a D-amino acid oxidase inhibitor, on perceived stress and cognitive function among patients with late-life depression: a randomized …

CH Lin, SH Wang, HY Lane - International Journal of …, 2022 - academic.oup.com
Background Compared with adults with depression in the general population, elderly
depressive patients are prone to poor treatment response, more side effects, and early …

Toward a personalized therapy for panic disorder: preliminary considerations from a work in progress

D Caldirola, G Perna - Neuropsychiatric disease and treatment, 2019 - Taylor & Francis
Although several treatment options for panic disorder (PD) are available, the best
intervention for each individual patient remains uncertain and the use of a more …

[HTML][HTML] Metabolic abnormalities related to treatment with selective serotonin reuptake inhibitors in patients with schizophrenia or bipolar disorder

KK Fjukstad, A Engum, S Lydersen… - Journal of Clinical …, 2016 - journals.lww.com
Objective The aim of the present study was to examine the effect of selective serotonin
reuptake inhibitors (SSRIs) on cardiovascular risk factors in patients with schizophrenia or …

The association between panic disorder and coronary artery disease among primary care patients presenting with chest pain: an updated literature review

DA Katerndahl - Primary care companion to the Journal of clinical …, 2008 - psychiatrist.com
Context: Although panic disorder is linked to hypertension and smoking, the relationship
between panic disorder and coronary artery disease (CAD) is unclear. Objective: To extend …

[HTML][HTML] Metabolic risk in depression and treatment with selective serotonin reuptake inhibitors: are the metabolic syndrome and an increase in cardiovascular risk …

M Chávez-Castillo, Á Ortega, M Nava, J Fuenmayor… - Vessel Plus, 2018 - oaepublish.com
Depression is one of the most common psychiatric disorders, and has become an epidemic
in modern medical practice; notorious for frequently co-occurring with multiple comorbidities …

[HTML][HTML] The effects of sertraline on blood lipids, glucose, insulin and HBA1C levels: a prospective clinical trial on depressive patients

M Kesim, A Tiryaki, M Kadioglu, E Muci… - Journal of research in …, 2011 - ncbi.nlm.nih.gov
BACKGROUND: In this study, we aimed to investigate the possible effects of sertraline on
blood glucose and lipid levels as risk factors for cardiovascular disease in depressive …

[HTML][HTML] Selective serotonin reuptake inhibitors and risk reduction for cardiovascular disease in patients with schizophrenia: A controversial but promising approach

A Bellon, K Nguyen - World Journal of Psychiatry, 2021 - ncbi.nlm.nih.gov
Patients with schizophrenia (SCZ) are at high risk of cardiovascular disease (CVD) due to an
inherited predisposition, a sedentary life style and the use of antipsychotic medications …

Metabolic Syndrome in patients with major depressive disorder: Associated risk factors

JW Goethe, BL Szarek, K Blank, CF Caley - Psychiatric Times, 2009 - go.gale.com
It has long been recognized that certain metabolic conditions are associated with
cardiovascular disease and increased risk for morbidity and mortality.(1, 2) These alterations …